# Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects

> **NCT03803644** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** CC-92480
- **DRUG:** CC-92480

## Key facts

- **NCT ID:** NCT03803644
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-21
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-05-28
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03803644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03803644, "Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03803644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*